During the last session, MoonLake Immunotherapeutics (NASDAQ:MLTX)’s traded shares were 1.19 million, with the beta value of the company hitting 1.26. At the end of
In today’s recent session, 0.55 million shares of the MoonLake Immunotherapeutics (NASDAQ:MLTX) have been traded, and its beta is 1.26. Most recently the company’s share
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
